Supplementary Figure 1 from Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8&lt;sup&gt;+&lt;/sup&gt; T Cells and Monocyte/Dendritic Cell Precursors